Record
Loading…
Record
Loading…
organization
Vertex Pharmaceuticals is an American pharmaceutical company, headquartered in Boston. It reported revenue of $11.02B for the period ended .
| fact | value | valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About → | confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About → | sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read. |
|---|
"sameAs": ["https://www.wikidata.org/wiki/Q2744099", "https://asof.is/record/vertex-pharmaceuticals"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_vertex-pharmaceuticals" }| quarterly net income | 1,082,900,000 United States dollar | sec.gov: 1 source for quarterly net income, claim clm_2FE795B3AF8B |
|---|---|---|
| quarterly operating income | 1,186,200,000 United States dollar | sec.gov: 1 source for quarterly operating income, claim clm_7EF8A5505C22 |
| quarterly research and development | 603,100,000 United States dollar | sec.gov: 1 source for quarterly research and development, claim clm_CF81367A05A7 |
| quarterly revenue | sec.gov: 1 source for quarterly revenue, claim clm_8AB184162D82 | |
| research and development | sec.gov: 1 source for research and development, claim clm_A31B2D7AAD7A | |
| shares outstanding | sec.gov: 1 source for shares outstanding, claim clm_663C199EF289 | |
| total equity | sec.gov: 1 source for total equity, claim clm_1E5EC8CA7B8E |